Nav: Home

Research suggests new therapeutic target for kidney diseases

May 04, 2020

(Boston)--Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.

Kidney podocytes are special octopus-like cells that are critical in maintaining the kidney glomerular filtering system and normal kidney function. This is the first time the ROBO2 pathway has been linked to glomerular diseases such as membranous nephropathy (affecting the filters) and focal segmental glomerulosclerosis (scarring in the kidney).

Chronic kidney disease affects an estimated 37 million people in the United States and more than 850 million people worldwide, and causes substantial morbidity and mortality worldwide. A significant proportion of patients with chronic kidney disease eventually will develop kidney failure and need dialysis or kidney transplantation to prolong their life.

Researchers at Boston University School of Medicine (BUSM) analyzed two induced kidney podocyte injury experimental models and found that those models without the ROBO2 gene were protected from kidney injury, while those with the ROBO2 gene developed severe kidney damage after kidney injury. Using cell culture analysis, they also found that higher ROBO2 protein levels resulted in reduced podocyte adhesion.

"As ROBO2 podocyte expression is well conserved among different mammalian species, our research suggests that ROBO2 is a novel drug target for glomerular diseases such as membranous nephropathy and focal segmental glomerulosclerosis, which is one of the most common causes of kidney failure in patients with no cure or treatment currently available," said corresponding author, Weining Lu, MD, associate professor of medicine and pathology & laboratory medicine at BUSM.

In collaboration with Pfizer, Lu's research has led to a compound targeting the ROBO2 pathway, which is currently being tested in phase 2 clinical trials for chronic kidney disease. "The study may ultimately lead to new treatment for patients so they can live to normal life expectancy on their own kidney and avoid dialysis or kidney transplantation."
-end-
These findings appear online in the American Journal of Pathology.

Funding for this study was provided in part by a National Institute of Health grant R01DK078226 (WL), R01DK090029 (DJS), research funding from Pfizer's Centers for Therapeutic Innovation (WL), and a cooperative matching grant from the Massachusetts Life Sciences Center (WL).

Note to Editors: Dr. Lu's work has been partially funded by Pfizer's Centers for Therapeutic Innovation. He and other authors from Boston University School of Medicine receive no other compensations or owns stock in the company. KC, CTB, DHS, SRA, HY, SPB are Pfizer employees and receive compensation from the company.

Boston University School of Medicine

Related Chronic Kidney Disease Articles:

Your neighborhood may raise your risk of chronic kidney disease
A neighborhood's overall socioeconomic status, including income and education-level, may influence its residents' risk of chronic kidney disease, according to a study recently published in SSM Population Health by researchers from Drexel University's Dornsife School of Public Health.
These lifestyle choices can reduce the risk of chronic kidney disease
Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports.
SGLT2 inhibitors can slow progression of chronic kidney disease
The CREDENCE trial [3] provided evidence that the SGLT2 inhibitor Canagliflozin slows the progression of CKD in individuals with type 2 diabetes (T2D) and CKD with albuminuria.
Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.
New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.
Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).
New tool predicts five-year risk of chronic kidney disease
A new risk calculator tool that uses a mix of variables including age, hypertension, and diabetes status can be used to predict accurately whether someone is likely to develop chronic kidney disease within five years.
Gap in care found for patients with chronic kidney disease: study
Millions of Canadians living with chronic kidney disease (CKD) may be going without critical testing from their primary care practitioners that would give them a good idea of the severity of the disease so they could intervene earlier with more appropriate care, according to a new study.
Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.
Men with chronic kidney disease have worse outcomes than women
Researchers at the University of Illinois at Chicago have found that men with chronic kidney disease, or CKD, are more likely to experience disease progression and death when compared with women suffering from the same condition.
More Chronic Kidney Disease News and Chronic Kidney Disease Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.